Navigation Links
InterCure Announces 100,000th RESPeRATE Unit Sold
Date:1/24/2008

Awareness and Adoption of Safe, Non-Drug Option to Lower Blood Pressure

Accelerates

NEW YORK, Jan. 24 /PRNewswire/ -- InterCure, Ltd. (Tel Aviv Stock Exchange: INCR) manufacturer of the RESPeRATE(R) hypertension treatment device, clinically-proven to significantly lower blood pressure, today announced it sold its 100,000th RESPeRATE device during the 2007 holiday season. This milestone marks a period of widespread consumer adoption and physician support for the novel technology and provides strong momentum for the RESPeRATE launch into retail pharmacies planned for later this year.

It took approximately four years to generate the first 50,000 unit sales of RESPeRATE, as clinical evidence, physician advocacy and consumer awareness began to take hold following the OTC clearance of the device. The second 50,000 units were sold in just 15 months. Growth is being driven through increased traction in the U.S. direct-to-consumer and online retail channels.

RESPeRATE has driven record volume through the world's leading e-commerce provider, Amazon.com, providing insight into the brand's sales potential within the retail environment. "RESPeRATE was among the top 100 items in our health and personal care store this holiday season," said Brett Barrilleaux, senior buyer at Amazon.com. "The brand's growth this year underscores our shoppers' desire for non-drug solutions in hypertension management."

"InterCure is experiencing robust growth in our core direct-to-consumer and online retail businesses. This reflects the growing consumer adoption rate for the RESPeRATE device and will serve us well as we expand our distribution into chain drugstores," said Erez Gavish, president and CEO of InterCure, manufacturer of the RESPeRATE device. "This year, we have been able to lay a solid foundation for our next phase of growth. Our traditional DTC business is healthier than it has ever been, and we have now assembled a world
'/>"/>

SOURCE InterCure, Ltd.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Childrens Mental Focus Foundation Announces a Scientific Breakthrough for Children Who Have Been Diagnosed With Autism, ADD and ADHD
2. Genaera Announces Diabetes IND In Effect for Trodusquemine (MSI-1436)
3. Beckman Coulter Announces Licensing Agreements for Molecular Tests with National University of Ireland, Galway
4. iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product
5. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
6. CeloNova BioSciences Announces Positive Results from European Study of Embozene(TM) Microspheres for Treatment of Uterine Fibroids
7. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
8. CeNeRx BioPharma Announces Successful Completion of Phase l Clinical Program for Novel Antidepressant Agent Tyrima(TM)
9. Morria Biopharmaceuticals Plc Announces Preliminary Safety and Tolerability Results From Its Phase I Clinical Study of MRX-4 in Allergic Rhinitis Patients
10. Anthera Announces Preliminary Positive Results From Once-Daily A-002 Phase II Cardiovascular Trial
11. Juvaris BioTherapeutics Announces Cooperative Research and Development Agreement With The Centers for Disease Control and Prevention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Calif. , May 21, 2013 /PRNewswire/ ... ), a specialty pharmaceutical company focused on ... for the treatment of acute and breakthrough ... in a placebo-controlled Phase 3 study of ... analgesia) System (NanoTab System), the primary efficacy ...
(Date:5/20/2013)... May 21, 2013   ... world,s health ministers gather to address the large physical ... and neurological disorders (MNDs) affect 700 million people annually ... (NCD) burden ,Do You Mind?, helps patients, ... each can play to collectively address MNDs , ...
(Date:5/20/2013)... MINNEAPOLIS , May 20, 2013  Uroplasty, Inc. ... will release financial results for the fiscal fourth quarter ... market close on Thursday, May 30, 2013. The Company ... these results on Thursday, May 30, 2013 at 4:30 ... to participate in the conference call should dial 888-549-7750, ...
Breaking Medicine Technology:Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 2Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 3Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 4Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 5Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 6Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 7Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 8Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 9Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 10Research-based Pharmaceutical Industry Launches 'Do You Mind?' Campaign to Fight Mental and Neurological Disorders 2Uroplasty To Announce Fiscal Fourth Quarter And Full Year 2013 Financial Results On May 30, 2013 2
(Date:5/21/2013)... 2013 Diehard soccer fans will definitely want ... the game between Manchester City and Chelsea FC ... These two teams are highly decorated in the English ... A-game to the Busch Stadium, home of the St. Louis ... first time that a professional sporting event and non-baseball game ...
(Date:5/21/2013)... HealthDay Reporter , , TUESDAY, May 21 (HealthDay News) -- ... some of the changes brought about by the disorder ... New research has found that people with diabetes who ... risk of having a severe low blood sugar (hypoglycemia) ... people with diabetes who aren,t depressed. "Depression ...
(Date:5/21/2013)... has awarded New York University neuroscientist J. Anthony Movshon ... his "pioneering work on the neuroscience of vision." ... Neural Science, is the second NYU neuroscience professor to ... the honor in 2011 in recognition of his "seminal ... fear learning, and fear memory." , Movshon, a ...
(Date:5/21/2013)... OK (PRWEB) May 21, 2013 Representatives with ... been such a success that the company has achieved its ... plan from day one was to move Hammerhead Bicycles from ... Spokesman and President Scott Robertson. , Robertson explained that the ... and continue to exclusively focus on all things 29er and ...
(Date:5/21/2013)... COLUMBUS, OHIO, MAY 21, 2013 Three major Ohio ... of Dimes Foundation to establish a new collaborative research ... premature birth. The March of Dimes intends to invest ... , "The March of Dimes Prematurity Research Center -- ... Jennifer L. Howse, President of the March of Dimes. ...
Breaking Medicine News(10 mins):Health News:Manchester City vs. Chelsea FC Tickets: Cheap Concert Tickets has Slashed Prices on Manchester City vs. Chelsea FC Tickets at Busch Stadium in St. Louis, MO 2Health News:Depression May Raise Low Blood Sugar Risk in Diabetics 2Health News:Depression May Raise Low Blood Sugar Risk in Diabetics 3Health News:NYU's Movshon receives Lashley Award for his research on the neuroscience of vision 2Health News:Hammerhead Bicycles Now a Standalone Brand 2Health News:New multi-million dollar research center aims to solve the mystery of premature birth 2Health News:New multi-million dollar research center aims to solve the mystery of premature birth 3
... Associates, LLC,announced today that it has issued an ... Board: BOCX). The full 52-page,report can be found ... or "the Company") is a biotechnology company,developing products ... global oncology market forecast to reach over $50 ...
... Establishes Effects of Puzzle ... and Word Games on the Human Body and Mind, ... Carolina,University,s Department of Recreation and Leisure Studies today revealed,the ... measured,the stress-relieving and other mood-lifting effects of so-called "casual",video ...
... of the major side effects of pain therapy for ... Food and Drug Administration on April 24, 2008, for ... patients receiving palliative care for advanced illness such as ... for Medicinal Products for Human Use, also rendered a ...
... Company -, LAVAL, QC, April 28 /PRNewswire-FirstCall/ ... that Claire Brulle, M.D. has been appointed,Senior Vice-President ... Medical Officer Dr. Sylvie Bouchard has retired from ... "Dr. Brulle brings to Labopharm a proven ...
... 1,440 Stores in May 2008, NEW YORK ... medical,device company publicly traded on the Tel Aviv ... hypertension treatment device,clinically-proven to significantly lower blood pressure, ... Kingdom this May through,Lloyds Pharmacy, the leading community ...
... 28 Readers in Europe and other parts of,the ... debut book,from London-born author Shireen Jeejeebhoy. It tells the ... medical history as the first,person to live long-term strictly ... has just scooped awards in the US for Editor,s ...
Cached Medicine News:Health News:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on BioCurex, Inc. 2Health News:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on BioCurex, Inc. 3Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 2Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 3Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 4Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 5Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 6Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 7Health News:Drug developed at the University of Chicago wins FDA approval 2Health News:Drug developed at the University of Chicago wins FDA approval 3Health News:Drug developed at the University of Chicago wins FDA approval 4Health News:Labopharm Appoints Dr. Claire Brulle as Senior Vice-President and Chief Medical Officer 2Health News:InterCure Secures Nationwide Distribution Agreement With Lloyds Pharmacy Group 2Health News:InterCure Secures Nationwide Distribution Agreement With Lloyds Pharmacy Group 3Health News:InterCure Secures Nationwide Distribution Agreement With Lloyds Pharmacy Group 4Health News:Story of Woman's Courage and Medical Innovation Top Choice for Readers 2
... For maximum productivity, and proven ... a compact, fully automatic cell washing ... a fast 80-second wash cycle for ... touch controls, and standardized, reproducible procedures. ...
Excellent all-around performance in digital format - MIC-D offers an exciting new way to observe the natural world. Multiple performance features provide new ways to enjoy microscope observation....
... refrigerated floor model centrifuge. High throughput, ... full speed with all windshield rotors, ... collected at a remote personal computer ... include automatic imbalance detection and shut ...
... low speed refrigerated centrifuge. Instant rotor ... patented system, comprehensive control using VIDEOset ... individual password protection of programs, 10 ... run profiles), powerful refrigeration 4C or ...
Medicine Products: